| Cerbahealthcare

GROUP
Cerba HealthCare’s mission is to support the evolution from a curative health system towards a more preventive system.

Discover our group
Diagnosis expertise
Every day, clinical pathology helps us take care of our health by providing data that enlightens the clinician's medical diagnosis and prescription.

Discover our diagnosis expertise
INNOVATIONS
Since 1967, we have been innovating to support scientific and technological progress in the service of diagnosis, prevention and precision medicine for all.

Discover our innovations
- Medical innovation
- SERVICE INNOVATION
News
CERBA INSTITUTE
Alongside associations and its public and institutional partners, the Cerba Institute is mobilizing to support patients, health professionals and research teams.

Discover Cerba Institute
- Supported projects
- Our governance

AdobeStock_659850869

Taxonomie_blue

News

01 February 2024

Cerba HealthCare named 2024 Best Employer by Capital magazine

Read more about Supervisory Board

CEO

Emmanuel joined Cerba HealthCare in 2024.

He has had a distinguished career in the healthcare sector. As Chairman and CEO of Cytiva (formerly GE HealthCare Life Sciences) since 2017, he has accelerated the growth trajectory of the group, which doubled sales in recent years. Before taking the helm at Cytiva, Emmanuel held a number of key positions in North America, Europe, the Middle East and Africa.
Emmanuel began his career in the late 90s in Japan with Otsuka Pharmaceutical before joining Abbott.

AdobeStock_117013463

Taxonomie_blue

White paper

03 March 2020

Respectful care of obese patients in clinical pathology laboratories

AdobeStock_58708006

Taxonomie_blue

Press release

20 October 2022

Cerba and taliaz to leverage Artificial intelligence and genetics expertise to improve patient care management in depression

image_chc_equity

Taxonomie_blue

Press release

30 March 2021

Cerba HealthCare welcomes EQT Group as new shareholder to foster innovation and better respond to new health issues

AdobeStock_58708006

Taxonomie_blue

Press release

19 July 2021

METAFORA biosystems, l’AP-HP ET Cerba HealthCare ont présenté les résultats de l’étude de validation du test METAglut1 lors du 3ème congrès européen sur le syndrome de deficit en Glut1.